P8 Is a New Target of Gemcitabine in Pancreatic Cancer Cells

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-05-1700
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Cyclopentenyl Cytosine Increases Gemcitabine Radiosensitisation in Human Pancreatic Cancer Cells

British Journal of Cancer
Cancer ResearchOncology
2008English

SRC Inhibition Is Still a Relevant Target in Pancreatic Cancer

Oncologist
Cancer ResearchMedicineOncology
2014English

Aspirin Inhibits Proliferation of Gemcitabine-Resistant Human Pancreatic Cancer Cells and Augments Gemcitabine-Induced Cytotoxicity

Acta Pharmacologica Sinica
MedicinePharmacology
2009English

Loss of PDPK1 Abrogates Resistance to Gemcitabine in Label-Retaining Pancreatic Cancer Cells

BMC Cancer
Cancer ResearchOncologyGenetics
2018English

FF-10502, an Antimetabolite With Novel Activity on Dormant Cells, Is Superior to Gemcitabine for Targeting Pancreatic Cancer Cells

Journal of Pharmacology and Experimental Therapeutics
Molecular MedicinePharmacology
2018English

Validation of TPX2 as a Potential Therapeutic Target in Pancreatic Cancer Cells

Clinical Cancer Research
Cancer ResearchOncology
2009English

Hypoxia Increases Resistance of Human Pancreatic Cancer Cells to Apoptosis Induced by Gemcitabine

Clinical Cancer Research
Cancer ResearchOncology
2004English

Two-Wave Nanotherapy to Target the Stroma and Optimize Gemcitabine Delivery to a Human Pancreatic Cancer Model in Mice

ACS Nano
Materials ScienceNanoscienceEngineeringNanotechnologyAstronomyPhysics
2013English

Microarray Analysis of Circular RNA Expression Profiles Associated With Gemcitabine Resistance in Pancreatic Cancer Cells

Oncology Reports
MedicineCancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy